ÂÜÀòÂÒÂ×

Bruna Blauth, MS, has extensive experience in regulatory affairs, currently serving as Associate Director of Regulatory Strategy at Sarepta Therapeutics since June 2022, having previously held the role of Senior Manager in the same department. Prior experience includes five years at Emergent BioSolutions, where Bruna managed regulatory activities for various vaccine programs and oversaw a team of regulatory professionals. Bruna's career also includes roles at Coté Orphan, where strategic regulatory pathways for orphan drug development were defined, and at Unither Virology, focusing on regulatory submissions for preclinical and clinical development. Educational qualifications include a Master’s Degree in Biotechnology with a focus on Regulatory Affairs from the University of Maryland Global Campus and a Bachelor of Science in Biochemistry from Virginia Tech.